Return-to-Work Screening by Linear Discriminant Analysis of Heart Rate Variability Indices in Depressed Subjects.

autonomic dysregulation depression discriminant analysis heart rate variability return-to-work screening sick leave

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
30 Jul 2021
Historique:
received: 15 06 2021
revised: 24 07 2021
accepted: 25 07 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 12 8 2021
Statut: epublish

Résumé

Using a linear discriminant analysis of heart rate variability (HRV) indices, the present study sought to verify the usefulness of autonomic measurement in major depressive disorder (MDD) patients by assessing the feasibility of their return to work after sick leave. When reinstatement was scheduled, patients' HRV was measured using a wearable electrocardiogram device. The outcome of the reinstatement was evaluated at one month after returning to work. HRV indices including high- and low-frequency components were calculated in three conditions within a session: initial rest, mental task, and rest after task. A linear discriminant function was made using the HRV indices of 30 MDD patients from our previous study to effectively discriminate the successful reinstatement from the unsuccessful reinstatement; this was then tested on 52 patients who participated in the present study. The discriminant function showed that the sensitivity and specificity in discriminating successful from unsuccessful returns were 95.8% and 35.7%, respectively. Sensitivity is high, indicating that normal HRV is required for a successful return, and that the discriminant analysis of HRV indices is useful for return-to-work screening in MDD patients. On the other hand, specificity is low, suggesting that other factors may also affect the outcome of reinstatement.

Identifiants

pubmed: 34372412
pii: s21155177
doi: 10.3390/s21155177
pmc: PMC8347333
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Health, Labour and Welfare
ID : 180201-01

Références

Neuropsychopharmacol Rep. 2020 Sep;40(3):239-245
pubmed: 32627417
J Psychiatr Res. 2017 Dec;95:28-36
pubmed: 28772111
Psychiatry Res. 2013 Dec 30;214(3):254-9
pubmed: 24139959
BMC Public Health. 2014 Feb 26;14:205
pubmed: 24571641
Psychiatry Clin Neurosci. 2017 Feb;71(2):135-145
pubmed: 27987241
Front Psychiatry. 2016 Nov 04;7:180
pubmed: 27867364
Percept Mot Skills. 2000 Dec;91(3 Pt 2):1091-105
pubmed: 11219651
Front Bioeng Biotechnol. 2018 May 22;6:64
pubmed: 29872656
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:1316-1319
pubmed: 29060118
Ind Health. 2019 Feb 5;57(1):22-28
pubmed: 30101896
Circulation. 1996 Mar 1;93(5):1043-65
pubmed: 8598068
Psychiatry Clin Neurosci. 2008 Oct;62(5):603-9
pubmed: 18950382
Am J Physiol. 1985 Oct;249(4 Pt 2):H867-75
pubmed: 4051021
Stat Med. 1998 Nov 30;17(22):2635-50
pubmed: 9839354
Exp Physiol. 2011 Dec;96(12):1255-61
pubmed: 21890520
Clin Exp Pharmacol Physiol. 1991 Nov;18(11):735-42
pubmed: 1782721
Biol Psychiatry. 2010 Jun 1;67(11):1067-74
pubmed: 20138254
Psychiatry Clin Neurosci. 2014 Mar;68(3):225-33
pubmed: 24313703
J Med Eng Technol. 2018 Feb;42(2):121-127
pubmed: 29569983
Ind Health. 2013;51(2):165-71
pubmed: 23095329
Med Biol Eng Comput. 1997 Jul;35(4):318-22
pubmed: 9327605
J Clin Psychiatry. 2000;61 Suppl 1:33-8
pubmed: 10703761

Auteurs

Toshikazu Shinba (T)

Department of Psychiatry, Shizuoka Saiseikai General Hospital, Shizuoka 422-8527, Japan.
Autonomic Nervous System Consulting, Shizuoka 420-0839, Japan.

Keizo Murotsu (K)

Department of Psychiatry, Shizuoka Saiseikai General Hospital, Shizuoka 422-8527, Japan.
Department of Psychiatry, Shizuoka Red Cross Hospital, Shizuoka 420-0853, Japan.

Yosuke Usui (Y)

Department of Psychiatry, Shizuoka Red Cross Hospital, Shizuoka 420-0853, Japan.

Yoshinori Andow (Y)

Yoga Mental Clinic, Tokyo 158-0097, Japan.

Hiroshi Terada (H)

Aoi Clinic, Shizuoka 420-0033, Japan.

Nobutoshi Kariya (N)

Maynds Tower Mental Clinic, Tokyo 151-00053, Japan.

Yoshitaka Tatebayashi (Y)

Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.

Yoshiki Matsuda (Y)

Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.

Go Mugishima (G)

School of Human and Social Sciences, Fukuoka Prefectural University, Tagawa 825-8585, Japan.

Yujiro Shinba (Y)

Autonomic Nervous System Consulting, Shizuoka 420-0839, Japan.

Guanghao Sun (G)

Graduate School of Informatics and Engineering, The University of Electro-Communications, Tokyo 182-8585, Japan.

Takemi Matsui (T)

Graduate School of System Design, Tokyo Metropolitan University, Tokyo 191-0065, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH